Airsculpt Technologies is trading at $2.82, up 5.62% on August 21, 2026, amid broader market and healthcare strength, without a clear company-specific announcement.
- The S&P 500, Nasdaq, and Dow are all higher during regular trading, supporting risk appetite.
- Healthcare is outperforming, helped by optimism around Moderna and Merck’s personalized cancer-vaccine results.
- Recent earnings weakness remains the main company-specific backdrop but does not explain today’s gain.